Adverse Events with Biomedicines

Prevention Through Understanding

  • Giuseppe Tridente

Table of contents

  1. Front Matter
    Pages i-xxx
  2. General Aspects

    1. Front Matter
      Pages 1-1
    2. Giuseppe Tridente
      Pages 3-14
    3. Giuseppe Tridente
      Pages 15-24
    4. Giuseppe Tridente
      Pages 25-47
  3. Monoclonal Antibodies

    1. Front Matter
      Pages 49-49
    2. Giuseppe Tridente
      Pages 51-63
    3. Giuseppe Tridente
      Pages 65-70
    4. Giuseppe Tridente
      Pages 71-80
    5. Giuseppe Tridente
      Pages 81-95
    6. Giuseppe Tridente
      Pages 97-104
    7. Giuseppe Tridente
      Pages 105-112
    8. Giuseppe Tridente
      Pages 113-125
    9. Giuseppe Tridente
      Pages 127-133
    10. Giuseppe Tridente
      Pages 135-142
    11. Giuseppe Tridente
      Pages 143-148
    12. Giuseppe Tridente
      Pages 149-158
    13. Giuseppe Tridente
      Pages 159-172
    14. Giuseppe Tridente
      Pages 173-182
    15. Giuseppe Tridente
      Pages 183-192

About this book


This monograph gathers and evaluates data on adverse events (AEs) associated specifically with those “biomedicines” – monoclonal antibodies, fusion proteins, and cytokines – that have recently entered therapeutic use in humans. All AEs observed when using each member of this new drug class are covered, with a view to improving understanding of pathogenesis, facilitating prevention, monitoring, and control, and contributing to the development of better drugs that provide benefits while minimizing risk. Further aspects here examined include the role of drug mechanisms of action and immunogenicity in relation to AEs outcome and induction of systemic syndromes. Additional data on AEs in off-label treatments are also considered.

Electronic data sheets, downloadable from the Springer Extra Materials platform, include more detailed safety data as well as additional basic information on product characteristics, pre- and post-marketing AEs classified according to frequency, and system/organ targeting. Data on excipients and selected information on drug interactions and associations are also provided. Adverse Events with Biomedicines: Prevention Through Understanding will serve as a detailed, practical guideline to this important new area, which demands the attention of clinicians, immunologists, oncologists, allergologists, public health professionals, and drug companies.


Adverse events (AEs) Antireceptor biologics Biomedicines or biologics Cytokines Fusion proteins Monoclonal antibodies (moAbs) Safety profiles Soluble receptor analogs

Authors and affiliations

  • Giuseppe Tridente
    • 1
  1. 1.University of VeronaVeronaItaly

Bibliographic information

  • DOI
  • Copyright Information Springer-Verlag Italia 2014
  • Publisher Name Springer, Milano
  • eBook Packages Biomedical and Life Sciences
  • Print ISBN 978-88-470-5312-0
  • Online ISBN 978-88-470-5313-7
  • About this book